UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000044591
Receipt No. R000050651
Scientific Title The study for identifying the antigen of culprit agents of perioperative anaphylaxis
Date of disclosure of the study information 2021/06/18
Last modified on 2021/06/18 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The study for identifying the antigen of culprit agents of perioperative anaphylaxis
Acronym The study for identifying the antigen of culprit agents of perioperative anaphylaxis
Scientific Title The study for identifying the antigen of culprit agents of perioperative anaphylaxis
Scientific Title:Acronym The study for identifying the antigen of culprit agents of perioperative anaphylaxis
Region
Japan

Condition
Condition Anaphylaxis
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Identify the antigenic site of the causative agent in patients with anaphylaxis
Basic objectives2 Others
Basic objectives -Others Diagnosis
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Basophil activation tests conducted 4 to 6 weeks after anaphylaxis
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Maneuver
Interventions/Control_1 Blood sampling
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Those who have had anaphylaxis during the perioperative period
Key exclusion criteria Those who the doctor deems inappropriate for participating in this study
Target sample size 40

Research contact person
Name of lead principal investigator
1st name Tomonori
Middle name
Last name Takazawa
Organization Gunma University Hospital
Division name Intensive Care Unit
Zip code 371-8511
Address 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511
TEL 027-220-8454
Email takazawt@gunma-u.ac.jp

Public contact
Name of contact person
1st name Kazuhiro
Middle name
Last name Nagumo
Organization Gunma University Hospital
Division name Department of Anesthesiology
Zip code 371-8511
Address 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511
TEL 027-220-8454
Homepage URL
Email m1920023@gunma-u.ac.jp

Sponsor
Institute Gunma University Hospital, Department of Anesthesiology
Institute
Department

Funding Source
Organization Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Gunma University Hospital, Department of Anesthesiology
Address 3-39-15 Showa-machi, Maebashi, Gunma, Japan 371-8511
Tel 027-220-8454
Email m1920023@gunma-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 06 Month 18 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 05 Month 20 Day
Date of IRB
Anticipated trial start date
2021 Year 06 Month 03 Day
Last follow-up date
2036 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 06 Month 18 Day
Last modified on
2021 Year 06 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050651